Intra-Cellular Therapies was founded on Dr. Paul Greengard’s Nobel Prize-winning research that uncovered how therapies affect the inner-working of cells in the body. The company leverages this intracellular approach to deliver treatments for complex psychiatric and neurologic diseases.